Lung Neoplasms: all 7,334 studies
Page 53 of 74. Open to participants first (1,555), then studies with results posted, then the rest; newest registration first within each.
- Identification of Predictive and Prognostic Markers for Lung Cancer With MetastasesActive, not recruitingNCT02301858Not applicable
- LUMINIST: LUng Cancer Molecular Insights Non Interventional StudyCompletedNCT02300831
- Personalized Sequence for Thoracic, Esophageal, and H&N CancerStatus unknownNCT02299622
- Pharmacokinetic and Safety Study of Lower Doses of Ceritinib Taken With a Low-fat Meal Versus 750 mg of Ceritinib in the Fasted State in Adult Patients With (ALK-positive) Metastatic Non-small Cell Lung Cancer (NSCLC)CompletedNCT02299505Phase 1
- A Study For Patients With EGFRm (Epidermal Growth Factor Receptor Mutant) Lung CancerWithdrawnNCT02297425Phase 2
- Next-generation Sequencing of Small Cell Lung Cancer to Identify Actionable Targets for TreatmentTerminatedNCT02297087Not applicable
- Salivary Biomarkers for Non-small Cell Lung Cancer DetectionStatus unknownNCT02294578
- Study of Safety and Efficacy of LEE011 and Ceritinib in Patients With ALK-positive Non-small Cell Lung Cancer.CompletedNCT02292550Phase 1
- PCORI-CER-1306-03385 Lung Cancer Screening Readiness StudyStatus unknownNCT02292485
- Video-Based Intervention in Reducing Anxiety in Patients Undergoing Lung Cancer ScreeningCompletedNCT02288416Not applicable
- Comparison of Different Types of Surgery in Treating Patients With Early-stage Non-small Cell Lung CancerStatus unknownNCT02288026
- HD+ I-scan Bronchoscopy Vascular Abnormalities Detection Multicenter StudyCompletedNCT02285426
- Blood Sample Monitoring of Patients With EGFR Mutated Lung CancerStatus unknownNCT02284633
- The Comparative Study on Rh-Endostatin (Endostar®) Continuous Intravenous Infusion and Routine i.v in Combination With GP Regimens for Phase III B/IV Squamous Cell Lung Cancer and Biological Markers Exploration.Status unknownNCT02283476Phase 3
- A Study of BIND-014 (Docetaxel Nanoparticles for Injectable Suspension) as Second-line Therapy for Patients With KRAS Positive or Squamous Cell Non-Small Cell Lung CancerCompletedNCT02283320Phase 2
- Expression and Sequence of Calcium Channels in Non-small Cell Lung Carcinoma (NSCLC)Status unknownNCT02283021
- Multicenter Randomized Controlled Trial Adjuvant Chemotherapy vs Observation in pStage Ib Lung AdenocarcinomaStatus unknownNCT02281708Phase 3
- NGS Genome Analysis in Personalisation of Lung Cancer TreatmentCompletedNCT02281214Not applicable
- A First-in-human Study to Evaluate the Safety, Tolerability and Pharmacokinetics of DS-6051bCompletedNCT02279433Phase 1
- Personalized Adaptive Radiation Therapy With Individualized Systemic Targeted Therapy (PARTIST) for Locally Advanced, Non-small Cell Lung Cancer With Genomic Driver MutationsWithdrawnNCT02277457Early Phase 1
- Role of Bronchoscopy in Early Lung Cancer Screening of High Risk PopulationTerminatedNCT02277366
- Cisplatin/Irinotecan With Concurrent Radiation for Inoperable NSCLCTerminatedNCT02275806Phase 2
- Randomized Study of Preoperative Dexamethasone for Quality of Recovery in VATS Lung Resection PatientsCompletedNCT02275702Phase 4
- Safety, Tolerability, Pharmacokinetics and Anti-tumour Activity of AC0010 in Advanced Non Small Cell Lung CancerStatus unknownNCT02274337Phase 1/2
- NovellusDx Functional Profiling of Oncogenic Mutations in Lung Cancer PatientsCompletedNCT02274025
- Comprehensive Genomic Analysis in Tissue and Blood Samples From Young Patients With Lung CancerCompletedNCT02273336
- Effect of Symptom Management on Inflammation and Survival in Metastatic Lung CancerCompletedNCT02271581
- Expanded Access Study of Alectinib for Participants With Anaplastic Lymphoma Kinase (ALK)-Rearranged Non-Small Cell Lung Cancer (NSCLC) After Disease Progression on or Intolerance to Prior ALK Tyrosine Kinase Inhibitor TherapyNo longer availableNCT02271139
- Diagnosis of Individuals With Pulmonary Nodules by Different Bronchoscopy CombinationStatus unknownNCT02268162Not applicable
- Lombardi Comprehensive Cancer Center/Legacy Pilot Study to Reduce Adverse Smoking Outcomes in the Context of Lung Cancer ScreeningCompletedNCT02267096Phase 3
- Vaccination of Advanced-Stage Lung Cancer PatientsWithdrawnNCT02264236Phase 1/2
- The Efficacy and Safety of Nab-paclitaxel in Pretreated Patients With Extensive Disease of Small Cell Lung CancerStatus unknownNCT02262897Phase 2
- Metabolomic and Epigenetic Profiling of Bodyfluids From Lung and Brain Cancer Receiving Radiation TherapyCompletedNCT02259218
- Extended Out-of-hospital Low-molecular-weight Heparin Prophylaxis Against DVT and PE in Patients Undergoing Major Lung ResectionCompletedNCT02258958
- Efficacy and Safety of Momelotinib Combined With Trametinib in Adults With Metastatic KRAS-mutated Non-Small Cell Lung Cancer (NSCLC) Who Have Failed Platinum-Based Chemotherapy Preceded by a Dose-finding Lead-in PhaseTerminatedNCT02258607Phase 1
- Exploratory Study of QBKPN SSI in Non-Small Cell Lung CancerCompletedNCT02256852Phase 2
- Phase I Hypofractionated Stereotactic Boost (Radiotherapy) for Non-Small Cell Lung CancerTerminatedNCT02252796Phase 1
- Study of EGFR-TKI to Asymptomatic Brain Metastases of NSCLCStatus unknownNCT02250846Phase 2
- Molecular Signatures of Relapse in Tissue Samples From Patients With Small Cell Lung Cancer Who Are Receiving Cisplatin and EtoposideWithdrawnNCT02250404
- Stereotactic Radiosurgery Followed by Wedge Resection in Treating Patients With Early Stage Peripheral Non-small Cell Lung CancerWithdrawnNCT02250378Not applicable
- Plasma microRNA Profiling as First Line Screening Test for Lung Cancer Detection: a Prospective StudyActive, not recruitingNCT02247453Not applicable
- The Role of Sedation Technique in EBUS-TBNACompletedNCT02245295
- Circulating Tumor DNA in Predicting Outcomes in Patients With Stage IV Head and Neck Cancer or Stage III-IV Non-small Cell Lung CancerCompletedNCT02245100
- Iloprost in Preventing Lung Cancer in Former SmokersCompletedNCT02237183Phase 1
- Study to Evaluate Real-world Pharmacoeconomics of Crizotinib in NSCLC PatientsTerminatedNCT02228421
- Oral Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors, AZD3759 or AZD9291, in Patients Who Have Advanced Non-Small Cell Lung CancerCompletedNCT02228369Phase 1
- Cisplatin, Docetaxel, and Nintedanib Before Surgery in Treating Patients With Previously Untreated Stage IB-IIIA Non-small Cell Lung CancerCompletedNCT02225405Phase 1
- Risk-adapted Stereotactic Body Radiotherapy for Early Non-Small Cell Lung Cancer Using the VERO Stereotactic Body Radio Therapy SystemStatus unknownNCT02224547Phase 2
- Clinical Observation of S1 Capsule for Stage Ⅱ-ⅢA Non-small Cell Lung Cancer After Complete ResectionStatus unknownNCT02223611Phase 2
- Bioequivalence & Food Effect Study in Patients With Solid Tumor or Hematologic MalignanciesCompletedNCT02223052Phase 1
- The Value of Surgical Mediastinal Staging in Clinical N1 Lung CancerCompletedNCT02222194
- Icotinib With Concurrent Radiotherapy Versus Chemotherapy With Concurrent Radiotherapy in Non-small Cell Lung CancerStatus unknownNCT02215356Phase 2
- SPECTAlung: Screening Patients With Thoracic Tumors for Efficient Clinical Trial AccessCompletedNCT02214134
- A Study Evaluating RO5479599 in Combination With Carboplatin and Paclitaxel in Participants With Advanced or Metastatic Non-Small-Cell Lung Cancer (NSCLC) of Squamous HistologyTerminatedNCT02204345Phase 1/2
- Study of Changes of Lymphocyte Subsets in Chemotherapy Course of Patients With Non-small Cell Lung CancerStatus unknownNCT02202655
- The Safety and Efficacy of Pemetrexed Rechallenge With BevacizumabTerminatedNCT02200354Phase 2
- Randomized Study of Maintenance Therapy With MGN1703 in Patients With SCLCCompletedNCT02200081Phase 2
- Dose-escalation Study of BIBH 1 in Patients With Non-small Cell Lung Cancer Scheduled for Surgical ResectionTerminatedNCT02199886Phase 1
- Yoga Program for Lung Cancer Patients and CaregiversCompletedNCT02196844Not applicable
- Chemotherapy Combined With Yangzhengxiaoji Capsule in Patients With Advanced Non-Small Cell Lung CancerStatus unknownNCT02195453Phase 4
- dMR During First Line Treatment of Non Squamous Lung Cancer: Time Course and Prognostic and Predictive Impact.Status unknownNCT02195336Not applicable
- Non Invasive Detection of Lung and Breast Cancer by Odor SignatureStatus unknownNCT02195076
- Genetic Testing in Screening Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been or Will Be Removed by Surgery (The ALCHEMIST Screening Trial)Active, not recruitingNCT02194738Not applicable
- Sequential and Maintenance Icotinib Plus Chemotherapy Versus Icotinib Maintenance After Chemotherapy in Advanced NSCLCStatus unknownNCT02194556Phase 4
- Cisplatin, Etoposide and PI3K Inhibitor BKM120 in Treating Patients With Advanced Solid Tumors or Small Cell Lung CancerCompletedNCT02194049Phase 1
- An Open Study of ASP8273 in Patients With Non-Small-Cell Lung Cancer (NSCLC) Who Have Epidermal Growth Factor Receptor (EGFR) MutationsTerminatedNCT02192697Phase 1/2
- Phase II Clinical Study of Intermittent High Dose of Icotinib in Combination With Docetaxel to Treat Lung CancerStatus unknownNCT02191059Phase 2
- Postoperative Radiotherapy of Non-small Cell Lung Cancer: Accelerated vs. Conventional FractionationCompletedNCT02189967Not applicable
- Screening for Early Lung Cancer in Shanghai, ChinaStatus unknownNCT02185495Phase 2
- EUCROSS: European Trial on Crizotinib in ROS1 Translocated Lung CancerCompletedNCT02183870Phase 2
- Study of Small Doses of Etoposide as Maintenance Treatment in Small Cell Lung Cancer(SCLC)Status unknownNCT02179528Phase 2
- Maintenance Low Dose Oral Navelbine In Patients With Non Small Cell Lung Cancer - MA.NI.LA TrialCompletedNCT02176369Phase 2
- Immunomagnetic Detection of Cancer Cells in Pleural Effusion in Lung Cancer Patients as Additional Staging and Prognostic ToolWithdrawnNCT02172027
- Study of Different Doses of Irinotecan and Cisplatin for First-line Extensive-stage Small-cell Lung Cancer TreatmentStatus unknownNCT02171325Phase 2
- Clinical Registry for Oligometastic Disease, Consolidation Therapy, Debulking Prior to Chemotherapy, or Re-IrradiationCompletedNCT02170181
- Molecular Diagnosis on Circulating Tumor DNA of Non-Small Cell Lung CancerCompletedNCT02169349
- A Study of Cabazitaxel for Patients With Breast or Lung Cancer and Recurrent or Progressive Brain Metastases - Cabazitaxel for Brain Metastases (CaBaMet)TerminatedNCT02166658Phase 2
- Ethaselen for the Treatment of Thioredoxin Reductase High Expression Advanced Non-small Cell Lung CancersCompletedNCT02166242Phase 1
- Therapeutic Strategies in Patients With Non-squamous Non-small Cell Lung Cancer With Brain MetastasesTerminatedNCT02162537Phase 3
- Aprepitant for Chemotherapy Induced Nausea and Vomiting in Chinese Advanced Non-small Cell Lung CancersCompletedNCT02161991Phase 3
- The Impact of Lung Cancer-derived Fibroblasts on Mast Cells ActivationCompletedNCT02161523
- RONICICLIB / Placebo in Combination With Chemotherapy in Small Cell Lung CancerTerminatedNCT02161419Phase 2
- One Step Nucleic Acid Amplification in Endobronchial Ultrasound-guided Needle Aspiration SamplesStatus unknownNCT02157857
- EF5 in Measuring Tumor Hypoxia in Patients With Stage I-III Non-Small Cell Lung CancerCompletedNCT02154399Phase 2
- A Study to Evaluate the Good and Bad Effects of BIBF1120 in Small Cell Lung Cancer Patients Who Have Previously Benefited From First-line Platinum-based ChemotherapyWithdrawnNCT02152059Phase 2
- Does Intense Regimented Surveillance Improve the Rates of Therapeutic Re-Intervention After Lung Cancer SurgeryCompletedNCT02149576Phase 2
- Incentive Spirometry Added to Physiotherapy to Reduce Postoperative Pulmonary Complications After Lung SurgeryCompletedNCT02146092Phase 2
- A Pharmacodynamic Study of Sirolimus and Metformin in Patients With Advanced Solid TumorsCompletedNCT02145559Phase 1
- Evolution of Corporeal Composition in the PeriOperative PeriodCompletedNCT02143869
- Ph1 to Assess Safety, Tolerability of Tremelimumab/ Tremelimumab+MEDI4736 in Japanese Solid Malignancies/ MesotheliomaCompletedNCT02141347Phase 1
- Safety Study of Human MUC-1 (Mucin-1) Adenoviral Vector Vaccine for Immunotherapy of Epithelial CancersStatus unknownNCT02140996Phase 1
- A Phase II Trial Measuring the Integration of Stereotactic Radiotherapy Plus Surgery in Early Non-Small Cell Lung CancerCompletedNCT02136355Not applicable
- Erlotinib Hydrochloride in Treating Non-Small Cell Lung Cancer That is Metastatic or Cannot be Removed by Surgery in Patients With HIV InfectionTerminatedNCT02134886Phase 1
- A Phase II Multi-center Pilot Study of Concurrent Temozolomide and Whole Brain Irradiation in Lung Cancer and Breast Cancer Patients With Brain MetastasesStatus unknownNCT02133677Phase 2
- Dignity Therapy/Life Plan in Patients With Pancreatic or Advanced Lung CancerCompletedNCT02132325Not applicable
- Continuing Evaluation of the LungPoint ATV SystemTerminatedNCT02130128Not applicable
- Auranofin and Sirolimus in Treating Patients With Advanced Solid Tumors or Recurrent Non-Small Cell Lung CancerWithdrawnNCT02126527Phase 1
- Hemodynamic Changes During One Lung Ventilation in Non-intubated Vedio-assisted Thoracoscopic OperationsCompletedNCT02123173
- Registry Measuring the Impact of Adding RNA Expression Testing on Referral Decisions in Early Stage Lung Cancer Patients and Assessing the Disease-free Survival With Long-term Follow-upTerminatedNCT02121925
- Registry Measuring Impact of RNA Expression Testing on Treatment Decisions in Early Stage Lung Cancer and Assessing the Disease-free Survival With Long-term Follow-up (ONC006)TerminatedNCT02121899